Defence Therapeutics Inc. DTCFF
0.23 USD -0.03 -10.27%
As of Nov 2, 3:25 PM ET
0.2333 52-week range 0.7787
- YTD
- -58.16%
- 1 year
- -60.14%
- Open
- 0.2333
- Prev close
- 0.26
- Mkt cap
- 17.68M
- Vol
- 2.50K
- Avg vol
- 10.15K
- EPS
- -0.08
- P/E
- 0.00
More statistics
- Low
- 0.2333
- High
- 0.2333
MAX chart
Chart tools
Chart is warming up
The all-time price history for DTCFF has not been loaded yet. Try again in a moment.
Altman Z-Score
-4.12 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
P/E -4.4×
P/S 0.0×
P/B 7.7×
P/FCF -5.9×
EV/EBITDA -5.7×
EV/Sales 0.0×
FCF Yield -17.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -184.2%
ROIC -91.0%
ROA -99.3%
Revenue 0.0%
Operating Income -60.7%
EPS (diluted) -92.7%
Free Cash Flow -53.3%
Current Ratio 3.4×
Quick Ratio 3.4×
Debt / Equity 0.5×
Net Debt / EBITDA 0.0×
Interest Coverage -12.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-06-30
